Trial intelligence / Profile preview

Filgrastim for Biliary Atresia

NCT04373941Phase 2Unknown

Start
Sep 2023
Primary completion
Aug 2024
Modality
Cytokines & Interferons
Countries
3
01

Overview

A Phase 2 trial of filgrastim in biliary atresia. Status: unknown.

02

Drugs

filgrastim
03

Conditions

biliary atresia

Beyond the preview

Go deeper on NCT04373941.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04373941.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call